449 related articles for article (PubMed ID: 21097776)
1. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair.
Bradford PT; Goldstein AM; Tamura D; Khan SG; Ueda T; Boyle J; Oh KS; Imoto K; Inui H; Moriwaki S; Emmert S; Pike KM; Raziuddin A; Plona TM; DiGiovanna JJ; Tucker MA; Kraemer KH
J Med Genet; 2011 Mar; 48(3):168-76. PubMed ID: 21097776
[TBL] [Abstract][Full Text] [Related]
2. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm.
Kraemer KH; Lee MM; Andrews AD; Lambert WC
Arch Dermatol; 1994 Aug; 130(8):1018-21. PubMed ID: 8053698
[TBL] [Abstract][Full Text] [Related]
3. Melanoma and other skin cancers in xeroderma pigmentosum patients and mutation in their cells.
Takebe H; Nishigori C; Tatsumi K
J Invest Dermatol; 1989 May; 92(5 Suppl):236S-238S. PubMed ID: 2715657
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation in the XPA gene associated with unusually mild clinical features in a patient who developed a spindle cell melanoma.
Sidwell RU; Sandison A; Wing J; Fawcett HD; Seet JE; Fisher C; Nardo T; Stefanini M; Lehmann AR; Cream JJ
Br J Dermatol; 2006 Jul; 155(1):81-8. PubMed ID: 16792756
[TBL] [Abstract][Full Text] [Related]
5. Auditory analysis of xeroderma pigmentosum 1971-2012: hearing function, sun sensitivity and DNA repair predict neurological degeneration.
Totonchy MB; Tamura D; Pantell MS; Zalewski C; Bradford PT; Merchant SN; Nadol J; Khan SG; Schiffmann R; Pierson TM; Wiggs E; Griffith AJ; DiGiovanna JJ; Kraemer KH; Brewer CC
Brain; 2013 Jan; 136(Pt 1):194-208. PubMed ID: 23365097
[TBL] [Abstract][Full Text] [Related]
6. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
[TBL] [Abstract][Full Text] [Related]
7. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
[TBL] [Abstract][Full Text] [Related]
8. Forty years of research on xeroderma pigmentosum at the US National Institutes of Health.
Kraemer KH; DiGiovanna JJ
Photochem Photobiol; 2015; 91(2):452-9. PubMed ID: 25220021
[TBL] [Abstract][Full Text] [Related]
9. Ocular manifestations of xeroderma pigmentosum: long-term follow-up highlights the role of DNA repair in protection from sun damage.
Brooks BP; Thompson AH; Bishop RJ; Clayton JA; Chan CC; Tsilou ET; Zein WM; Tamura D; Khan SG; Ueda T; Boyle J; Oh KS; Imoto K; Inui H; Moriwaki S; Emmert S; Iliff NT; Bradford P; Digiovanna JJ; Kraemer KH
Ophthalmology; 2013 Jul; 120(7):1324-36. PubMed ID: 23601806
[TBL] [Abstract][Full Text] [Related]
10. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum.
Kraemer KH; Lee MM; Scotto J
Carcinogenesis; 1984 Apr; 5(4):511-4. PubMed ID: 6705149
[TBL] [Abstract][Full Text] [Related]
11. Development of effective skin cancer treatment and prevention in xeroderma pigmentosum.
Lambert WC; Lambert MW
Photochem Photobiol; 2015; 91(2):475-83. PubMed ID: 25382223
[TBL] [Abstract][Full Text] [Related]
12. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
[TBL] [Abstract][Full Text] [Related]
13. Xeroderma pigmentosum. Complementation group C and malignant melanoma.
Lynch HT; Fusaro RM; Johnson JA
Arch Dermatol; 1984 Feb; 120(2):175-9. PubMed ID: 6696469
[No Abstract] [Full Text] [Related]
14. Xeroderma pigmentosum: recent clinical and photobiological aspects.
Kondo S; Fukuro S; Nishioka K; Satoh Y
J Dermatol; 1992 Nov; 19(11):690-5. PubMed ID: 1293156
[TBL] [Abstract][Full Text] [Related]
15. Xeroderma Pigmentosum: A Genetic Condition Skin Cancer Correlated-A Systematic Review.
Brambullo T; Colonna MR; Vindigni V; Piaserico S; Masciopinto G; Galeano M; Costa AL; Bassetto F
Biomed Res Int; 2022; 2022():8549532. PubMed ID: 35898688
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts.
Nikolaev S; Yurchenko AA; Sarasin A
Orphanet J Rare Dis; 2022 Mar; 17(1):104. PubMed ID: 35246173
[TBL] [Abstract][Full Text] [Related]
17. Cockayne syndrome and xeroderma pigmentosum.
Rapin I; Lindenbaum Y; Dickson DW; Kraemer KH; Robbins JH
Neurology; 2000 Nov; 55(10):1442-9. PubMed ID: 11185579
[TBL] [Abstract][Full Text] [Related]
18. Xeroderma pigmentosum in the United kingdom.
Lehmann AR
Photochem Photobiol; 2015; 91(2):484-5. PubMed ID: 24943090
[TBL] [Abstract][Full Text] [Related]
19. The present status of xeroderma pigmentosum in Japan and a tentative severity classification scale.
Nakano E; Masaki T; Kanda F; Ono R; Takeuchi S; Moriwaki S; Nishigori C
Exp Dermatol; 2016 Aug; 25 Suppl 3():28-33. PubMed ID: 27539899
[TBL] [Abstract][Full Text] [Related]
20. Shining a light on xeroderma pigmentosum.
DiGiovanna JJ; Kraemer KH
J Invest Dermatol; 2012 Mar; 132(3 Pt 2):785-96. PubMed ID: 22217736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
